SMYD3 and cancer: To assess SMYD3 involvement in the “enabling replicative immortality” cancer hallmark, we analyzed in silico the corresponding Telomere Maintenance Reactome pathway (Id: R-HSA-157579.5), which comprises 93 proteins, 28 of which contain P-tripeptides (Table 1 and Appendix Table S3).